FDA DTC Study Aims To Fool Consumers, But Not Doctors, In Use Of Fictitious Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Study examining design of print advertisements will be straightforward with doctors that a fictitious drug is being presented, while the wording for consumers will be ambiguous.